Nelito: What if in a year someone pays us 600 million for Lympro with a bunch of it in up front cash and the rest upon milestones.....along with some royalties on future revenues? That wouldn't be bad, either.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links